Federal award
SAREPTA THERAPEUTICS, INC.
W911QY12C0117
Contract
Obligated and Ceiling
- Obligated (net)
- $3,786,506.00
- Ceiling (potential value, not spending)
- $3,878,784.00
- Current value
- $3,878,784.00
- Gross positive obligations
- $6,180,934.10
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SAREPTA THERAPEUTICS, INC. · YKM9HZ3EH6X1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SAREPTA THERAPEUTICS, INC. · FVMHHCGQKM83
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W911QY12C0117
- Award type code
- D
- Actions
- 9 · Aug 29, 2012 to Sep 18, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 18, 2019 | FY2019 | P00008 | C | $302,150.10 | — |
| Feb 10, 2014 | FY2014 | P00007 | K | −$394,428.10 | — |
| Aug 20, 2013 | FY2013 | P00006 | B | $0.00 | — |
| May 21, 2013 | FY2013 | P00005 | C | $413,000.00 | — |
| Apr 12, 2013 | FY2013 | P00004 | C | $1,000,000.00 | — |
| Mar 25, 2013 | FY2013 | P00003 | M | $0.00 | — |
| Mar 12, 2013 | FY2013 | P00002 | C | $587,000.00 | — |
| Jan 4, 2013 | FY2013 | P00001 | C | −$2,000,000.00 | — |
| Aug 29, 2012 | FY2012 | 0 | — | $3,878,784.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.